Physician profile
Khin Ko
NPI 1417372582
$720.01
in general payments reported to CMS, 2019-2025
14 companies · $88.10 in 2025
The $88.10 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.36 · 2020: $102 · 2021: $116 · 2022: $70.25 · 2023: $172 · 2024: $130 · 2025: $88.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $187.79 | 2020-2022 | |
| Abbvie INC. | $144.37 | 2021-2024 | |
| Viiv Healthcare Company | $65.68 | 2023-2025 | Apretude, Cabenuva, Rukobia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.54 | 2023-2024 | Ofev |
| Allergan, INC. | $45.87 | 2019-2020 | |
| Gilead Sciences, INC. | $39.66 | 2020-2023 | |
| Dynavax Technologies Corporation | $29.78 | 2023 | Heplisav-B |
| Exact Sciences Corporation | $28.74 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $25.78 | 2025 | |
| Shionogi INC | $22.32 | 2024 | Fetroja |
| Merck Sharp & Dohme LLC | $21.11 | 2022 | |
| Emd Serono, INC. | $17.19 | 2023 | Serostim |
| Otsuka America Pharmaceutical, INC. | $16.25 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khin Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.